BioCatalyst

AT673 low dose, AT673 high dose — catalyst calendar

1 verified catalyst event(s) referencing AT673 low dose, AT673 high dose, each linked to its official source. Verified as of 2026-10-03.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02 (month)
in 4mo
ESTIMATED
 READOUT
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered
Phase 2 · Adults With Overweight/Obesity and Type 2 Diabetes
 Antag Therapeutics AT673 low dose, AT673 high dose ClinicalTrials.gov ↗
✓ Source-checked 2026-10-03
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.